Search results for:
measles/mumps/rubella virus vaccine, live
measles/mumps/rubella virus vaccine, live
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Priorix |
INJECTION, SUBCUTANEOUS |
0.5 mL |
|
|
|
|
M-M-R II, MMR |
POWDER FOR INJECTION, SUBCUTANEOUS |
- |
|
|
|
|
Last updated: Dec. 28, 2022
Restricted with a therapeutic interchange with the MMRII vaccine. The most cost effective product will be used per patient situation, healthcare setting, or hospital contract.
Reviewed: Dec. 2022 (Priorix)